Compton Capital Management Inc Biogen Inc. Transaction History

Compton Capital Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$223.92 - $287.77 $160,102 - $205,755	-715 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $14,149 - $18,452	-50 Reduced 6.54%	715 $202,000
Q1 2021 May 04, 2021	BUY	$242.95 - $284.63 $185,856 - $217,741	765 New	765 $214,000
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $180,738 - $272,056	-765 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $202,549 - $233,868	765 New	765 $217,000
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $172,008 - $227,795	-665 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$268.85 - $341.04 $34,950 - $44,335	-130 Reduced 16.35%	665 $210,000
Q4 2019 Feb 10, 2020	BUY	$220.06 - $304.07 $174,947 - $241,735	795 New	795 $236,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $171,851 - $268,795	-793 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $8,355 - $10,582	30 Added 3.93%	793 $239,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $6,438 - $7,672	25 Added 3.39%	763 $221,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $70,235 - $99,335	-270 Reduced 26.79%	738 $202,000
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $310,101 - $347,336	1,008	1,008 $321,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Compton Capital Management Inc with notifications on news.